Molnupiravir

Molnupiravir capsules What is molnupiravir? Molnupiravir is an investigational drug that is currently being researched as a potential therapy for patients with mild to moderate COVID-19. This medication is still being researched, therefore not all of its side effects have been uncovered. Molnupiravir is now approved for emergency use by the Food and Drug Administration of the United States (FDA) for the treatment of mild-to-moderate COVID-19 in people 18 years of age and older who test positive for COVID-19; who are at high risk for progression to severe COVID-19, including hospitalization or death; and for whom other COVID-19 treatment options are not available or applicable. This treatment is only for people who do not have access to other COVID-19 treatment options. Molnupiravir is not approved for the following applications: initiating therapy in patients who require hospitalization because of COVID-19; preventing infection with COVID-19 either before or after exposure to the virus; usage for more than 5 days in a row. Warnings Molnupiravir may now be used as an emergency therapy for patients with mild to moderate COVID-19, as permitted by the Food and Drug Administration (FDA) of the United States. Patients must be at least 18 years old. Before beginning to use this medication Inform your primary care physician if you suffer from any severe or ongoing illness. If either the mother or the father is using molnupiravir, there is a risk that the unborn child will be harmed by the medication: If you are a woman, do not use molnupiravir if you are pregnant. Use an efficient method of birth control to avoid becoming pregnant while taking this medication and for at least 4 days after you have finished your last dosage. If you are a guy and your sexual partner is pregnant or has the potential to get pregnant, you should utilize an effective method of birth control. Continue taking your birth control method for at least three months after you have finished your final dosage. Notify your healthcare provider as soon as possible if you become pregnant while taking molnupiravir, whether you are the mother or the father. Before beginning this therapy, it is recommended that you have a pregnancy test that comes back negative. If you are pregnant, there is a possibility that your name may be added to a pregnancy registry that will monitor the impact that molnupiravir has on the developing baby. When you are taking this medication and for at least 4 days following your final dosage, you should refrain from breastfeeding. You must discard any milk that you have collected while using a breast pump during this period. It is not safe for your infant to consume. Users who are less than 18 years old are not permitted to use this product. How do I go about administering the molnupiravir? Molnupiravir should be taken in the manner described in your physician's instructions. Read all of the medication guides or instruction papers that come with your medicine, and make sure to follow all of the guidelines that are included on the prescription label. Molnupiravir should be taken in doses of four capsules every 12 hours for a period of five days in a row. You should start taking this medication as soon as possible after receiving a diagnosis of COVID-19, and you should do so within 5 days after the onset of the first symptoms. Molnupiravir can be taken with or without food depending on your preference. Take the capsule as directed, without crushing, chewing, breaking, or opening it in any other way. Molnupiravir treatment will not make you less infectious to others around you or other people who have the virus. Maintain the use of infection management strategies such as self-isolation, social distance, hand washing, wearing a protective face covering, sanitizing surfaces you contact often, and avoiding exchanging personal goods with other people. Molnupiravir is currently being researched, therefore not all of the potential side effects have been identified. What can I expect if I forget to take a dose? You should take the medication as soon as you remember, but you should omit the missed dosage if it has been more than 10 hours after the scheduled time. It is not recommended to take two dosages at once. Molnupiravir side effects Molnupiravir can cause an allergic response that might manifest as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. If you have any of these symptoms, get immediate medical attention. Make an appointment with your primary care physician if any of your symptoms appear to be getting worse. Diarrhea, nausea, and dizziness are examples of common adverse reactions that may occur after using molnupiravir. What other medications might potentially interact with molnupiravir? Molnupiravir's effects might be altered by the use of other pharmaceuticals, such as prescription and over-the-counter medications, vitamins, and herbal treatments. Talk to your primary care physician about any other medications you use.